2 results match your criteria: ""Constantin I. Parhon" National Institute of Endocrinology[Affiliation]"
Well-differentiated neuroendocrine tumor and osteoporosis: incidental findings?
Rom J Morphol Embryol
July 2014
"Constantin I. Parhon" National Institute of Endocrinology, Bucharest, Romania;
The neuroendocrine tumors (NETs) have an increased incidence related to the age. Secondary osteoporosis might be found in patients with bone metastases and in those with NETs associated Cushing's disease or primary hyperparathyroidism. Primary osteoporosis might be found in postmenopausal women, but in case with non-metastatic NET as G1 NET it is difficult to establish the NET contribution to the bone loss.
View Article and Find Full Text PDFThe poor prognosis factors in G2 neuroendocrine tumor.
Rom J Morphol Embryol
July 2014
"Constantin I. Parhon" National Institute of Endocrinology, Bucharest, Romania;
Background: The G2 neuroendocrine tumors (NET) or well-differentiated neuroendocrine carcinomas (2010 WHO Classification of Tumours of the Digestive System) embrace different types of evolution despite the fact that they actually are included in the same group of prognosis based on mitotic count and the Ki-67 proliferation index.
Aim: We studied the pathological and clinical aspects in patients with G2 NET.
Materials And Methods: This is a retrospective pilot observational study in patients admitted between January 2008 and January 2013 in "Constantin I.